Drug Offers Long-Term Heart Protection for Childhood Cancer Survivors
- OPACC
- Feb 8, 2023
- 1 min read
When children with cancer received dexrazoxane alongside their chemotherapy, they tended to have fewer heart complications in the short and long term.
Comments